138 related articles for article (PubMed ID: 31491425)
1. pH balance and lactic acid increase in the vitreous body of diabetes mellitus patients.
Mieno H; Marunaka Y; Inaba T; Kojima K; Yoneda K; Nagata K; Sotozono C
Exp Eye Res; 2019 Nov; 188():107789. PubMed ID: 31491425
[TBL] [Abstract][Full Text] [Related]
2. Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
Jiang H; Du J; He T; Qu J; Song Z; Wu S
Clin Exp Ophthalmol; 2014 Dec; 42(9):841-5. PubMed ID: 24645972
[TBL] [Abstract][Full Text] [Related]
3. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
Barba I; Garcia-Ramírez M; Hernández C; Alonso MA; Masmiquel L; García-Dorado D; Simó R
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4416-21. PubMed ID: 20375324
[TBL] [Abstract][Full Text] [Related]
4. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
6. Association of vitreous vitamin C depletion with diabetic macular ischemia in proliferative diabetic retinopathy.
Park SW; Ghim W; Oh S; Kim Y; Park UC; Kang J; Yu HG
PLoS One; 2019; 14(6):e0218433. PubMed ID: 31216331
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy.
Mancino R; Di Pierro D; Varesi C; Cerulli A; Feraco A; Cedrone C; Pinazo-Duran MD; Coletta M; Nucci C
Mol Vis; 2011; 17():1298-304. PubMed ID: 21633716
[TBL] [Abstract][Full Text] [Related]
9. Unique molecular signatures of microRNAs in ocular fluids and plasma in diabetic retinopathy.
Smit-McBride Z; Nguyen AT; Yu AK; Modjtahedi SP; Hunter AA; Rashid S; Moisseiev E; Morse LS
PLoS One; 2020; 15(7):e0235541. PubMed ID: 32692745
[TBL] [Abstract][Full Text] [Related]
10. Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy.
Qiu F; He J; Zhou Y; Bai X; Wu G; Wang X; Liu Z; Chen Y; Ma JX; Liu Z
Eye (Lond); 2014 Apr; 28(4):402-9. PubMed ID: 24406409
[TBL] [Abstract][Full Text] [Related]
11. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
12. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
Koskela UE; Kuusisto SM; Nissinen AE; Savolainen MJ; Liinamaa MJ
Ophthalmic Res; 2013; 49(2):108-14. PubMed ID: 23257933
[TBL] [Abstract][Full Text] [Related]
13. Alteration of N-Glycan Profiles in Diabetic Retinopathy.
Inafuku S; Noda K; Amano M; Ohashi T; Yoshizawa C; Saito W; Murata M; Kanda A; Nishimura S; Ishida S
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5316-22. PubMed ID: 26258617
[TBL] [Abstract][Full Text] [Related]
14. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
[TBL] [Abstract][Full Text] [Related]
15. [pO2, pCO2 and acid-base balance in the human vitreous sample].
Sato Y; Tamai M
Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1295-9. PubMed ID: 1442356
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
Petrovic MG; Korosec P; Kosnik M; Hawlina M
Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
[TBL] [Abstract][Full Text] [Related]
18. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA
Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
[TBL] [Abstract][Full Text] [Related]
19. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
